• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Catalog Number 07P60-32
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/22/2023
Event Type  malfunction  
Event Description
The customer obtained non-reactive alinity i syphilis tp for 1 patient, and is stating that the results were not consistent with patient¿s history.The customer provided the following data (reference < 1.0 s/co is non-reactive).On (b)(6) 2023 ¿ syphilis result was 0.65 (non-reactive), generated from reagent lot: 50282be00, tested on alinity (b)(6).Historical syphilis results: on (b)(6) 2018 ¿ syphilis: reactive 11.62 s/co (abbott architect platform), vdrl: reactive.On (b)(6) 2019 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive.On (b)(6) 2020 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive.On (b)(6) 2020 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive there was no reported impact to patient management.
 
Manufacturer Narrative
This report is being filed on an international product, list number 7p60-32 and there is a similar product distributed in the us, list number 07p60-21 / 31.E1 phone: complete phone number: (b)(6).All available patient information was included.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer obtained non-reactive alinity i syphilis tp for 1 patient, and is stating that the results were not consistent with patient¿s history.The customer provided the following data (reference < 1.0 s/co is non-reactive).(b)(6) 2023 ¿ syphilis result was 0.65 (non-reactive), generated from reagent lot 50282be00, tested on alinity (b)(6).Historical syphilis results: (b)(6) 2018 ¿ syphilis: reactive 11.62 s/co (abbott architect platform), vdrl: reactive.(b)(6) 2019 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive.(b)(6) 2020 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive.(b)(6) 2020 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive there was no reported impact to patient management.
 
Manufacturer Narrative
Section h6 - adverse event problem, type of investigation coding was corrected.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in house testing.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Device history review did not identify any non-conformances or deviations with the complaint lot.The ticket search by lot indicates that the reagent lot 50282be00 perform as expected for this product.Ticket and trending review did not identify any related trends regarding commonalities for complaint lot numbers and customer issue.In-house testing was conducted on lot number 50281be01, which contains the same bulk material as, lot number 50282be00, and concluded which determined that all controls met specifications and no false non-reactive results were obtained.In house testing concluded that the expected results were generated.Labeling was reviewed and was found to address the customer reported issue.Based on the investigation, no systemic issue or deficiency was identified for alinity i syphilis tp reagent, lot number 50282be00.
 
Event Description
The customer obtained non-reactive alinity i syphilis tp for 1 patient, and is stating that the results were not consistent with patient¿s history.The customer provided the following data (reference < 1.0 s/co is non-reactive) (b)(6) 2023 ¿ syphilis result was 0.65 (non-reactive), generated from reagent lot 50282be00, tested on alinity (b)(6) historical syphilis results: (b)(6) 2018 ¿ syphilis: reactive 11.62 s/co (abbott architect platform), vdrl: reactive (b)(6) 2019 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive (b)(6) 2020 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive (b)(6) 2020 ¿ syphilis: reactive (siemens platform), vdrl: non-reactive there was no reported impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I SYPHILIS TP REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key17928267
MDR Text Key325802052
Report Number3002809144-2023-00429
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K153730
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/13/2024
Device Catalogue Number07P60-32
Device Lot Number50282BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/25/2023
Initial Date FDA Received10/12/2023
Supplement Dates Manufacturer Received01/04/2024
01/04/2024
Supplement Dates FDA Received01/04/2024
01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/20/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6) ; ALNTY I PROCESSING MODU, 03R65-01, (B)(6) ; ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
-
-